Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Small Molecules

Discovery & Development Analytical Science

Top Tips for mRNA Sequencing

We explore the potential of mRNA as therapeutics and the challenges associated with analysis and sequencing.

Business & Regulation Advanced Medicine

Gearing Up for the 2022 Power List and More

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Business & Regulation COVID-19

The Biggest Moments of 2021

The pharmaceutical industry experienced its fair share of challenges and success in 2021. We break down the sector's biggest moments here.

Discovery & Development Dosage Forms

Easy Film to Swallow, Hard Act to Follow?

EsoCap CEO Isabelle Racamier tells the story behind a new drug delivery technology that could supplant syrups and pills for illnesses of the esophagus

Discovery & Development Drug Discovery

Join The Resistance

| Maryam Mahdi

Antimicrobial resistance is an ongoing challenge for the pharmaceutical industry. What solutions can be created to address the problem?

Business & Regulation Business Practice

Teva Takes Hit in New York Opioid Case

| Stephanie Sutton

After other defendants in the case settle, Teva is left to face the music in New York alone.

Manufacture Technology and Equipment

The Innovation Awards 2021

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.

Manufacture Ingredients

Blue Light for Waste Reduction

| Angus Stewart

A team at the University of Bath have found a more efficient way to produce drugs using a catalyst powered by 420 nanometer blue light.

Discovery & Development Formulation

The Digital Future of Formulation

| Ferdinand-Paul Brandl

Integrating digital technologies into your operations can make all the difference to the formulation process.

Discovery & Development Drug Discovery

Slowing the Alzheimer’s Decline | The Medicine Maker Social

| Maryam Mahdi

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register